首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡格列酮联合克罗米芬在有胰岛素抵抗的多囊卵巢综合征治疗中的应用
引用本文:程亚辉,孟焱,黄桂芹,衡丽娜,敖健明,杨树兴,辛俊英.吡格列酮联合克罗米芬在有胰岛素抵抗的多囊卵巢综合征治疗中的应用[J].河北医学,2014,0(4):659-662.
作者姓名:程亚辉  孟焱  黄桂芹  衡丽娜  敖健明  杨树兴  辛俊英
作者单位:程亚辉(河北省围场满族蒙古族自治县妇幼保健院,河北 围场,068450);孟焱(河北省兴隆县中医 院,河北兴隆,067300);黄桂芹(河北省兴隆县人民医 院,河北兴隆,067300);衡丽娜(河北省承德市中医 院,河北承德,067000);敖健明(河北省围场满族蒙古族自治县妇幼保健院,河北 围场,068450);杨树兴(河北省承德市冯营子镇卫生 院,河北承德,067000);辛俊英(河北省承德市中医 院,河北承德,067000);
摘    要:目的:探讨吡格列酮联合克罗米芬治疗有胰岛素抵抗的多囊卵巢综合征的临床疗效。方法:选取我院在2011年10月至2012年10月收治的具有胰岛素抵抗的多囊卵巢综合征患者80例,随机分为对照组和治疗组各40例,对照组患者采用吡格列酮单独用药治疗,治疗组采用克罗米芬、吡格列酮联合用药治疗,比较两组患者的临床疗效以及治疗前后激素水平。结果:治疗3个月后,治疗组总有效率(95%)明显高于对照组总有效率(90%),两组间比较差异显著具有统计学意义( X2=4.1142,P<0.05);治疗后两组FSH、LH、T、FINS水平均较治疗前明显降低,差异比较极显著(t=2.8107,P<0.01;t=6.0965,P<0.01;t=18.5510,P<0.01;t=8.1710,P<0.01),具有统计学意义;治疗组治疗后FSH、LH、T、FINS水平明显低于对照组,差异比较显著具有统计学意义( t=1.9873,P<0.05;t=2.8220, P<0.05;t=2.3198,P<0.05;t=1.9794,P<0.05);此外,两组的不良反应发生率分别为2.5%、7.5%,差异不显著( P>0.05)。结论:吡格列酮联合克罗米芬治疗有胰岛素抵抗的多囊卵巢综合征临床疗效明显,并能改善激素水平,值得推广应用。

关 键 词:多囊卵巢综合征  胰岛素抵抗  吡格列酮  克罗米芬

The Effect of Pioglitazone Combined Clomiphene on Polycystic Ovary Syndrome with Insulin Resistance
Institution:CHENG Yahui, et al ( The Woman and Health Care Hospital of Weichang ,Hebei Weichang 068450, China)
Abstract:Objective:To investigate the effect of pioglitazone combined with clomiphene in treatment of polycystic ovary syndrome(PCOS)with insulin resistance.Method: 80 patients with polycystic ovary syn-drome(PCOS)with insulin resistance in our hospital from Oct .2011 to Oct.2012, were divided into control group and treatment group randomly , The patients in control group were given pioglitazone treatment , the treatment group with pioglitazone combined with clomiphene therapy;And then the clinical efficacy and ser-um level of hormone were compared before and after treatment .Result: Three months after treatment , The total effective rate in treatment group ( 95%) was superior to that in control group ( 90%) ,There's statistical significance (X2=4.1142,P <0.05), The serum level of FSH,LH,T,FINS decreased in both groups after treatment, There's statistical significant difference , (t=2.8107,P<0.01;t=6.0965,P<0.01;t=18.5510,P<0.01;t=8.1710,P<0.01) .The serum level of FSH ,LH,T,FINS in the treatment group decreased more obvi-ously,There'sstatistical significance (t=1.9873,P<0.05;t=2.8220,P<0.05;t=2.3198,P<0.05;t=1.9794, P<0.05);There's in significance in side effect rate in both groups (2.5%,7.5%), (P >0.05).Conclusion:It's effective to treat polycystic ovary syndrome with insulin resistance with pioglitazone and clomiphene , im-prove serum level of hormone , It's worth applying .
Keywords:PCOS  Insulin resistance  Pioglitazone  Clomiphene
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号